Mikko Rönty

2.0k total citations
49 papers, 1.6k citations indexed

About

Mikko Rönty is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Mikko Rönty has authored 49 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 11 papers in Oncology. Recurrent topics in Mikko Rönty's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Occupational and environmental lung diseases (8 papers) and Cellular Mechanics and Interactions (6 papers). Mikko Rönty is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers), Occupational and environmental lung diseases (8 papers) and Cellular Mechanics and Interactions (6 papers). Mikko Rönty collaborates with scholars based in Finland, United States and United Kingdom. Mikko Rönty's co-authors include Olli Carpén, Vuokko L. Kinnula, Carol Otey, Virinder Kaur Sarhadi, Aija Knuuttila, Wei Gu, Jae‐Woong Hwang, Marjukka Myllärniemi, David A. Dean and R. Saravanan and has published in prestigious journals such as Journal of Clinical Investigation, Bioinformatics and PLoS ONE.

In The Last Decade

Mikko Rönty

49 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikko Rönty Finland 21 615 596 303 261 200 49 1.6k
Ryoko Shimizu‐Hirota Japan 21 544 0.9× 365 0.6× 312 1.0× 328 1.3× 396 2.0× 35 1.8k
Suzette Riddle United States 20 796 1.3× 820 1.4× 406 1.3× 119 0.5× 124 0.6× 34 1.8k
Douglas W. Strand United States 27 1.0k 1.6× 835 1.4× 501 1.7× 529 2.0× 159 0.8× 73 2.4k
R. Scott Pearsall United States 25 1.4k 2.2× 376 0.6× 180 0.6× 300 1.1× 120 0.6× 62 2.4k
Andrew J. Haak United States 21 554 0.9× 420 0.7× 88 0.3× 171 0.7× 256 1.3× 57 1.5k
Wei Ding China 22 935 1.5× 379 0.6× 198 0.7× 323 1.2× 139 0.7× 66 1.6k
Mishie Tanino Japan 25 961 1.6× 650 1.1× 497 1.6× 533 2.0× 176 0.9× 117 2.3k
Ilona N. Holcomb United States 12 693 1.1× 239 0.4× 306 1.0× 284 1.1× 90 0.5× 19 1.5k
Hiroyuki Yanai Japan 25 624 1.0× 563 0.9× 121 0.4× 490 1.9× 128 0.6× 148 2.0k
Hajime Okita Japan 25 1.2k 2.0× 550 0.9× 200 0.7× 349 1.3× 93 0.5× 124 2.2k

Countries citing papers authored by Mikko Rönty

Since Specialization
Citations

This map shows the geographic impact of Mikko Rönty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikko Rönty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikko Rönty more than expected).

Fields of papers citing papers by Mikko Rönty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikko Rönty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikko Rönty. The network helps show where Mikko Rönty may publish in the future.

Co-authorship network of co-authors of Mikko Rönty

This figure shows the co-authorship network connecting the top 25 collaborators of Mikko Rönty. A scholar is included among the top collaborators of Mikko Rönty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikko Rönty. Mikko Rönty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lahtinen, Laura, Mikko Räsänen, Karita Peltonen, et al.. (2024). Ex vivo modeling of precision immuno-oncology responses in lung cancer. Science Advances. 10(44). eadq6830–eadq6830. 2 indexed citations
2.
Vesterinen, Tiina, Helena Leijon, Heini Huhtala, et al.. (2023). Immunohistochemical somatostatin receptor expression in insulinomas. Apmis. 131(4). 152–160. 5 indexed citations
3.
Vesterinen, Tiina, Helena Leijon, Heini Huhtala, et al.. (2023). Immunohistochemical Glucagon-like Peptide-1 Receptor Expression in Human Insulinomas. International Journal of Molecular Sciences. 24(20). 15164–15164. 8 indexed citations
4.
Repo, Pauliina, Eva Sutinen, Mikko Rönty, et al.. (2022). BAP1 germline variants in Finnish patients with malignant mesothelioma. Lung Cancer. 165. 102–107. 7 indexed citations
5.
Rönty, Mikko, et al.. (2022). Association of CT findings with invasive subtypes and the new grading system of lung adenocarcinoma. Clinical Radiology. 78(3). e251–e259. 6 indexed citations
6.
Rönty, Mikko, Christina Karlsson, Caj Haglund, et al.. (2019). Estrogen receptor beta expression correlates with proliferation in desmoid tumors. Journal of Surgical Oncology. 119(7). 873–879. 17 indexed citations
7.
Rönty, Mikko, Tom Böhling, Christina Karlsson, et al.. (2018). High cyclin A expression, but not Ki67, is associated with early recurrence in desmoid tumors. Journal of Surgical Oncology. 118(1). 192–198. 5 indexed citations
8.
Sarhadi, Virinder Kaur, Mikko Rönty, Eeva Kettunen, et al.. (2016). Hot spot mutations in Finnish non-small cell lung cancers. Lung Cancer. 99. 102–110. 19 indexed citations
9.
Yin, Miao, Mikko Rönty, Eva Sutinen, et al.. (2015). Overexpression of activin-A and -B in malignant mesothelioma – Attenuated Smad3 signaling responses and ERK activation promote cell migration and invasive growth. Experimental Cell Research. 332(1). 102–115. 25 indexed citations
10.
Rönty, Mikko, et al.. (2014). Epidermal Growth Factor Receptor Mutations in 510 Finnish Non–Small-Cell Lung Cancer Patients. Journal of Thoracic Oncology. 9(6). 886–891. 19 indexed citations
11.
12.
Syrjä, Pernilla, Eva Sutinen, Mikko Rönty, et al.. (2013). Comparative Study of Transforming Growth Factor-β Signalling and Regulatory Molecules in Human and Canine Idiopathic Pulmonary Fibrosis. Journal of Comparative Pathology. 150(4). 399–407. 18 indexed citations
13.
Rönty, Mikko, et al.. (2012). Cell culture model predicts human disease: Altered expression of junction proteins and matrix metalloproteinases in cervical dysplasia. BMC Clinical Pathology. 12(1). 9–9. 4 indexed citations
14.
Yao, Hongwei, Sangwoon Chung, Jae‐Woong Hwang, et al.. (2012). SIRT1 protects against emphysema via FOXO3-mediated reduction of premature senescence in mice. Journal of Clinical Investigation. 122(6). 2032–2045. 296 indexed citations
15.
Auvinen, Eeva, et al.. (2012). Altered Expression of ezrin, E-Cadherin and β-Catenin in Cervical Neoplasia. Neoplasma. 60(1). 56–61. 18 indexed citations
16.
Rönty, Mikko, Leena Heiska, Carol Otey, et al.. (2007). Palladin interacts with SH3 domains of SPIN90 and Src and is required for Src-induced cytoskeletal remodeling. Experimental Cell Research. 313(12). 2575–2585. 41 indexed citations
17.
Rönty, Mikko, Boris Hinz, Andrew Rachlin, et al.. (2006). Isoform-Specific Regulation of the Actin-Organizing Protein Palladin during TGF-β1-Induced Myofibroblast Differentiation. Journal of Investigative Dermatology. 126(11). 2387–2396. 72 indexed citations
18.
Rönty, Mikko, et al.. (2005). Involvement of palladin and α-actinin in targeting of the Abl/Arg kinase adaptor ArgBP2 to the actin cytoskeleton. Experimental Cell Research. 310(1). 88–98. 56 indexed citations
19.
Rönty, Mikko, et al.. (2004). Molecular analysis of the interaction between palladin and α‐actinin. FEBS Letters. 566(1-3). 30–34. 74 indexed citations
20.
Grönholm, Mikaela, Mikko Rönty, Maciej Łałowski, et al.. (2001). Characterization of Human Palladin, a Microfilament-associated Protein. Molecular Biology of the Cell. 12(10). 3060–3073. 129 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ryoko Shimizu‐Hirota Breakdown of academic impact, for papers by Suzette Riddle Breakdown of academic impact, for papers by Douglas W. Strand Breakdown of academic impact, for papers by R. Scott Pearsall Breakdown of academic impact, for papers by Andrew J. Haak Breakdown of academic impact, for papers by Wei Ding Breakdown of academic impact, for papers by Mishie Tanino Breakdown of academic impact, for papers by Ilona N. Holcomb Breakdown of academic impact, for papers by Hiroyuki Yanai Breakdown of academic impact, for papers by Hajime Okita
Rankless by CCL
2026